Skip to main content

Table 1 Treatment-related toxicities occurring during the 6-months following Ad5-GUCY2C-PADRE vaccination

From: Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients

Toxicity

Grade 1/2

Grade 3/4

Total (%)

Chills/Rigor

2

0

2 (20%)

Dizziness

1

0

1 (10%)

Diaphoresis

1

0

1 (10%)

Injection site or arm pain/swelling

2

0

2 (20%)

Aches

1

0

1 (10%)

Fever

1

0

1 (10%)

Back to article page